top of page

DoriVac: A Revolutionary DNA Origami Vaccine Platform


DoriVac is a groundbreaking DNA origami vaccine platform that has garnered significant attention in the field of biotechnology. Developed to enhance antigen-specific immune responses, DoriVac utilises DNA origami technology to precisely arrange molecules like adjuvants and antigens on nanoparticles, revolutionising the landscape of immunotherapy (Yang et al., 2024). This innovative platform can deliver multiple types of cargos with nanoscale precision, potentially leading to more effective and tailored healthcare solutions.

What is biotechnology?

Biotechnology in the medical field involves the application of biological processes and organisms to develop products and technologies for healthcare purposes. It plays a crucial role in advancing medical practices by enabling innovative diagnostic tools, treatments, and therapies that improve patient care and outcomes (Phuc, 2018)

In today's medical landscape, biotechnology is essential for several reasons:

1. Drug Development: Biotechnology facilitates the development of advanced medications like genetically engineered drugs and vaccines. These products are designed to target specific diseases more effectively, offering personalised treatment options for patients.

2. Genetic Engineering: Biotechnology allows for genetic modifications that can lead to breakthroughs in gene therapy. This approach involves correcting defective genes or introducing functional genes to treat genetic disorders at their root cause.

3. Precision Medicine: Biotechnology enables precision medicine, which tailors medical treatment to an individual's genetic makeup. By considering a patient's unique genetic profile, healthcare providers can offer personalised therapies that are more effective and have fewer side effects. (Ng, 2018)

Overall, biotechnology's impact on medical practices is profound, offering innovative solutions that enhance patient care, improve treatment efficacy, and pave the way for personalized medicine tailored to individual genetic profiles. By harnessing the power of biotechnological tools and techniques, healthcare professionals can address complex medical challenges more effectively and advance the field of medicine towards a more personalised and efficient future.

How is DoriVac relevant to the field of biotechnology?

The core mechanism of DoriVac lies in its ability to control the spacing and geometry of co-presented tumor antigens and adjuvants on the same particle, facilitating their synergistic action to induce a robust immune response (Yang et al., 2024). This innovative approach enables the delivery of multiple types of cargos with nanoscale precision, enhancing antigen-specific T cell activation and promoting anti-tumor immune responses with remarkable efficiency.  {3}  The study discovered that the most advantageous stimulation of APCs produced a highly-desirable profile of T cells, including those that kill cancer cells (cytotoxic T cells), those that induce beneficial inflammation (Th-1 polarised T cells), and those that provide a long-term immune memory of the tumour (memory T cells). These molecules of an adjuvant known as CpG spaced exactly 3.5 nanometers apart from each other. Tumour-bearing mice were able to better regulate the growth of their tumours and live a much longer life than control mice thanks to the DoriVac vaccine. Importantly, immune checkpoint inhibitors, a very effective immunotherapy that is currently being utilised extensively in clinics, and DoriVac's effects worked in concert (Wyss Institute, 2024)

Benefits of DoriVac and its applications

One of DoriVac's most striking features is its ability to tailor vaccines to individual patients, a concept known as personalised medicine. By customising the vaccine composition for each person, DoriVac maximises efficacy and minimise adverse effects, heralding a new era in targeted healthcare solutions. In comparison to other traditional vaccines, DoriVac also requires less antigens and adjuvants, making it a more cost-effective solution. 

DoriVac has shown promising results in various applications, including cancer immunotherapy, infectious disease prevention (e.g., SARS-CoV-2, HIV), and combating bacterial infections like E. coli and MRSA[5]. As researchers at institutions like the Wyss Institute at Harvard University delve into the development and application of DoriVac, they are unlocking new frontiers in cancer treatment. By enhancing immune responses through innovative vaccine design, DoriVac holds immense promise for combating cancers by leveraging advanced biotechnological strategies.  (Wyss Institute, 2024) 

Concerns and Considerations

While DoriVac presents a revolutionary approach to vaccine development, some concerns exist regarding its long-term safety profile and potential side effects. Additionally, the scalability and cost-effectiveness of manufacturing DoriVac vaccines for widespread use need to be further optimised to ensure accessibility and affordability. Other concerns and considerations behind the potential usage and marketing of DoriVac to the general public include:

  1. Obtaining regulatory approval from health authorities is a critical step in introducing DoriVac to the market. Compliance with regulatory standards and demonstrating efficacy will be key considerations. (Yang, 2022)

  2. Educating the public about the benefits and safety of DoriVac will be vital for acceptance. Addressing any misconceptions or concerns through transparent communication is essential for successful marketing.

  3.  Providing clear data on the efficacy of DoriVac in clinical trials and real-world settings will be crucial for building trust among healthcare providers and the general public.

  4. Addressing ethical considerations related to personalised medicine, genetic engineering, and informed consent will be important in marketing DoriVac responsibly.

  5. Understanding the competitive landscape and differentiating DoriVac from existing vaccines or treatments will be essential for successful market penetration.

By addressing these concerns and considerations thoughtfully, transparently, and effectively, the potential usage and marketing of DoriVac to the general public can be optimised, ensuring its successful integration into healthcare systems worldwide.

What’s in the Future for Dori-Vac? 

For university students delving into the intricacies of biotechnology, DoriVac serves as a beacon of complexity and innovation. Its fusion of DNA origami technology with immunotherapy not only expands scientific horizons but also challenges conventional paradigms in vaccine development, setting a new standard for precision medicine. Moving forward, research on DoriVac aims to explore its efficacy in personalised cancer vaccines, neoantigen targeting, and synergies with immune checkpoint therapies for enhanced anti-tumor responses (Yang et al., 2024). The platform's ability to induce immune memory and prevent cancer recurrence highlights its potential as a game-changer in cancer treatment strategies.

In conclusion, DoriVac emerges as a transformative force in the landscape of vaccines, blending scientific ingenuity with clinical impact to redefine how we approach disease prevention and treatment. DoriVac represents a cutting-edge advancement in vaccine technology, offering a novel approach to enhancing immune responses against various diseases. With ongoing research focusing on optimising its efficacy, safety profile, and scalability, DoriVac holds immense promise for revolutionising immunotherapy and personalised medicine in the near future.


Article prepared by: Chong Yuen Yeng, Research and Development Associate of MBIOS 23/24

If you enjoyed this article, do sign up to become a part of our MBIOS family and receive our monthly newsletter along with many more resources in the link below.



  1. Ng W. (2018). Biotechnology in Medical Sciences. The Yale Journal of Biology and Medicine, 91(3), 354. 

  2.  Phuc V. Pham, Chapter 19 - Medical Biotechnology: Techniques and Applications,Omics Technologies and Bio-Engineering, Academic Press, 2018, Pages 449-469, (

  3. Wyss Institute for Biologically Inspired Engineering at Harvard. (2024, March 15). DNA origami-based vaccines toward safe and highly effective precision cancer immunotherapy. ScienceDaily. Retrieved March 22, 2024 from 

  4. Yang C. Zeng (2022). Yang (Claire) Zeng on Developing DoriVac, the Next Generation of Vaccine Delivery Technology. Humans of the Wyss Yang (Claire) Zeng on Developing DoriVac (

  5. Yang C. Zeng, Olivia J. Young, Christopher M. Wintersinger, Frances M. Anastassacos, James I. MacDonald, Giorgia Isinelli, Maxence O. Dellacherie, Miguel Sobral, Haiqing Bai, Amanda R. Graveline, Andyna Vernet, Melinda Sanchez, Kathleen Mulligan, Youngjin Choi, Thomas C. Ferrante, Derin B. Keskin, Geoffrey G. Fell, Donna Neuberg, Catherine J. Wu, David J. Mooney, Ick Chan Kwon, Ju Hee Ryu, William M. Shih. Fine-tuning of CpG spatial distribution with DNA origami for improved cancer vaccination. Nature Nanotechnology, 2024; DOI: 10.1038/s41565-024-01615-3


Stay Up-To-Date with New Posts

Search By Tags

bottom of page